Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688739)"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 688739 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Liaoning Chengda Biotechnology Co. Ltd. on 6ix
Earlier from Liaoning Chengda Biotechnology
- (688739)"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- (688739)"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on Cancellation of Certain Repurchased Shares, Reduction of Registered Capital and Notice to Creditors
- Announcement on Change of Registered Capital and Amendments to the Articles of Association
- Announcement on Expiration of Shareholding Reduction Plan of Senior Executive and Results of Shareholding Reduction
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Liaoning Chengda Biotechnology into a list and get an email when it puts out news.
Follow Liaoning Chengda Biotechnology